Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-10

Clinical Trial Update: Efficacy of GLP-1 Receptor Agonists in Treating Upper and Lower Extremity Lymphedema [EARLY_Phase 1]

View source ↗

Summary

An early-phase clinical trial is evaluating GLP-1 receptor agonists for treating upper and lower-extremity lymphedema and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GLP-1 receptor agonists

Snippet

Sponsor: Advanced Reconstructive Surgery Alliance | Conditions: Lymphedema | EARLY_Phase 1 | Status: RECRUITING